open access

Vol 72, No 4 (2022)
Invited editorial
Published online: 2022-08-22
Get Citation

Are we ready to change treatment planning for left-side breast cancer radiotherapy?

Tomasz Piotrowski12, Julian Malicki12
DOI: 10.5603/NJO.2022.0038
·
Nowotwory. Journal of Oncology 2022;72(4):247-249.
Affiliations
  1. Department of Medical Physics, Greater Poland Cancer Centre, Poznan, Poland
  2. Department of Electroradiology, Poznan University of Medical Sciences, Poznan, Poland

open access

Vol 72, No 4 (2022)
Invited editorial
Published online: 2022-08-22

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Are we ready to change treatment planning for left-side breast cancer radiotherapy?

Journal

Nowotwory. Journal of Oncology

Issue

Vol 72, No 4 (2022)

Article type

Invited editorial

Pages

247-249

Published online

2022-08-22

Page views

76

Article views/downloads

55

DOI

10.5603/NJO.2022.0038

Bibliographic record

Nowotwory. Journal of Oncology 2022;72(4):247-249.

Authors

Tomasz Piotrowski
Julian Malicki

References (13)
  1. Poitevin-Chacón A, Chávez-Nogueda J, Prudencio RR, et al. Dosimetry of the left anterior descending coronary artery in left breast cancer patients treated with postoperative external radiotherapy. Rep Pract Oncol Radiother. 2018; 23(2): 91–96.
  2. Bukovszky B, Fodor J, Mátri Z. et l. Rdiotherpy insted of xillry lymph node dissection: evlution of xillry lymph node dose coverge with whole brest rdiotherpy. Rep Pract Oncol Radiother. 2022; ahead of print.
  3. Vogin G, Foray N. The law of Bergonié and Tribondeau: a nice formula for a first approximation. Int J Radiat Biol. 2013; 89(1): 2–8.
  4. Clarke M, Collins R, Darby S, et al. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366(9503): 2087–2106.
  5. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013; 368(11): 987–998.
  6. Sardaro A, Petruzzelli MF, D'Errico MP, et al. Radiation-induced cardiac damage in early left breast cancer patients: risk factors, biological mechanisms, radiobiology, and dosimetric constraints. Radiother Oncol. 2012; 103(2): 133–142.
  7. Atkins K, Bitterman D, Chaunzwa T, et al. Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2021; 110(5): 1473–1479.
  8. Mężeński P, Kukołowicz P. What new dose distribution statistics may be included in the optimization of dose distribution in radiotherapy for post-mastectomy patients. NOWOTWORY J Oncol. 2021; 71(5): 267–273.
  9. Zureick AH, Grzywacz VP, Almahariq MF, et al. Dose to the Left Anterior Descending Artery Correlates With Cardiac Events After Irradiation for Breast Cancer. Int J Radiat Oncol Biol Phys. 2022 [Epub ahead of print].
  10. Biedka M, Żmuda E. Contouring of the left anterior descending coronary artery in patients with breast cancer – the radiation oncologist’s view. NOWOTWORY J Oncol. 2020; 70(2): 60–64.
  11. van Velzen SGM, Gal R, Teske AJ, et al. AI-Based Radiation Dose Quantification for Estimation of Heart Disease Risk in Breast Cancer Survivors After Radiation Therapy. Int J Radiat Oncol Biol Phys. 2022; 112(3): 621–632.
  12. Zhang TW, Snir J, Boldt RG, et al. Is the Importance of Heart Dose Overstated in the Treatment of Non-Small Cell Lung Cancer? A Systematic Review of the Literature. Int J Radiat Oncol Biol Phys. 2019; 104(3): 582–589.
  13. El-Sherif O, Yu E, Xhaferllari I, et al. Assessment of Intrafraction Breathing Motion on Left Anterior Descending Artery Dose During Left-Sided Breast Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016; 95(3): 1075–1082.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl